CDH2 and cancer: Many studies on various cancer tissues have demonstrated dislocation and downregulation of epithelial markers including E-cadherin, plakoglobin, and cytokeratin; upregulation of mesenchymal markers such as N-cadherin and vimentin, and expression of the EMT transcriptional drivers, snail1/2 and Twist [19,45].